FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311349503> ?p ?o ?g. }

• W4311349503 endingPage "61" @default.
• W4311349503 startingPage "61" @default.
• W4311349503 abstract "<ns3:p><ns3:bold>Background:</ns3:bold> Recent studies show that adults with intellectual disabilities (ID) have high incidence of major osteoporotic fracture, especially hip fracture. In those ≥ 50 years, women and men with ID have an approximately two and four times higher rate of hip fracture than women and men without ID. Increased awareness of osteoporotic fracture risk in ID may lead to wider use of antiresorptiverugs (bisphosphonates and denosumab) in this population. We aimed to compare, between people with and without ID, the incidence of 1) major side effects, namely medication related osteoporosis of the jaw (ONJ) and oesophagitis; 2) oral pathology, which can be a risk factor for ONJ.</ns3:p><ns3:p> <ns3:bold>Methods:</ns3:bold> Exploratory study investigating safety of first line osteoporosis medication within the population of a previous study comparing fracture incidence in people with and without ID in the GOLD database of the Clinical Practice Research Datalink 1998-2017.</ns3:p><ns3:p> <ns3:bold>Results:</ns3:bold> The percentage of people on antiresorptive drugs was identical in the ID and non ID group (1.4%). The number of individuals who developed ONJ and oesophagitis during the study was too low to allow an accurate estimate of incidence of the events and a comparison between the two groups. The incidence of any oral pathology was 119.31 vs 64.68/10000 person year in the ID vs non ID group.</ns3:p><ns3:p> <ns3:bold>Conclusions:</ns3:bold> Medication related ONJ and oesophagitis are rare in people with and without ID. There is no reason based on our findings to use antiresorptives differently in people with ID as in the rest of the population. However, the potential for side effects of antiresorptives will inherently increase with wider use of these drugs. Given the higher incidence of oral pathology in people with ID, which could put them at higher risk of ONJ, precautions should be taken to prevent this complication by attention to oral health.</ns3:p>" @default.
• W4311349503 created "2022-12-25" @default.
• W4311349503 creator A5012944536 @default.
• W4311349503 creator A5030848728 @default.
• W4311349503 creator A5087534692 @default.
• W4311349503 date "2022-12-13" @default.
• W4311349503 modified "2023-10-12" @default.
• W4311349503 title "Use and risk of side effects of antiresorptive medication in people with intellectual disabilities" @default.
• W4311349503 cites W2070097037 @default.
• W4311349503 cites W2107208293 @default.
• W4311349503 cites W2119852447 @default.
• W4311349503 cites W2150035525 @default.
• W4311349503 cites W2360896406 @default.
• W4311349503 cites W2514269202 @default.
• W4311349503 cites W2515807663 @default.
• W4311349503 cites W2733593079 @default.
• W4311349503 cites W2802751184 @default.
• W4311349503 cites W2912931145 @default.
• W4311349503 cites W2942606895 @default.
• W4311349503 cites W2946269035 @default.
• W4311349503 cites W2982136187 @default.
• W4311349503 cites W3087153461 @default.
• W4311349503 cites W3199080619 @default.
• W4311349503 cites W4200152254 @default.
• W4311349503 cites W4213264012 @default.
• W4311349503 cites W4281255528 @default.
• W4311349503 cites W4286764453 @default.
• W4311349503 cites W4298149197 @default.
• W4311349503 doi "https://doi.org/10.3310/nihropenres.13352.1" @default.
• W4311349503 hasPublicationYear "2022" @default.
• W4311349503 type Work @default.
• W4311349503 citedByCount "0" @default.
• W4311349503 crossrefType "journal-article" @default.
• W4311349503 hasAuthorship W4311349503A5012944536 @default.
• W4311349503 hasAuthorship W4311349503A5030848728 @default.
• W4311349503 hasAuthorship W4311349503A5087534692 @default.
• W4311349503 hasBestOaLocation W43113495031 @default.
• W4311349503 hasConcept C120665830 @default.
• W4311349503 hasConcept C121332964 @default.
• W4311349503 hasConcept C126322002 @default.
• W4311349503 hasConcept C1862650 @default.
• W4311349503 hasConcept C2776286101 @default.
• W4311349503 hasConcept C2776541429 @default.
• W4311349503 hasConcept C2778885795 @default.
• W4311349503 hasConcept C2908647359 @default.
• W4311349503 hasConcept C61511704 @default.
• W4311349503 hasConcept C71924100 @default.
• W4311349503 hasConcept C99454951 @default.
• W4311349503 hasConceptScore W4311349503C120665830 @default.
• W4311349503 hasConceptScore W4311349503C121332964 @default.
• W4311349503 hasConceptScore W4311349503C126322002 @default.
• W4311349503 hasConceptScore W4311349503C1862650 @default.
• W4311349503 hasConceptScore W4311349503C2776286101 @default.
• W4311349503 hasConceptScore W4311349503C2776541429 @default.
• W4311349503 hasConceptScore W4311349503C2778885795 @default.
• W4311349503 hasConceptScore W4311349503C2908647359 @default.
• W4311349503 hasConceptScore W4311349503C61511704 @default.
• W4311349503 hasConceptScore W4311349503C71924100 @default.
• W4311349503 hasConceptScore W4311349503C99454951 @default.
• W4311349503 hasFunder F4320320620 @default.
• W4311349503 hasFunder F4320335361 @default.
• W4311349503 hasLocation W43113495031 @default.
• W4311349503 hasOpenAccess W4311349503 @default.
• W4311349503 hasPrimaryLocation W43113495031 @default.
• W4311349503 hasRelatedWork W1796982176 @default.
• W4311349503 hasRelatedWork W1808564681 @default.
• W4311349503 hasRelatedWork W2028911992 @default.
• W4311349503 hasRelatedWork W2139692423 @default.
• W4311349503 hasRelatedWork W2399635335 @default.
• W4311349503 hasRelatedWork W2418366216 @default.
• W4311349503 hasRelatedWork W2797187287 @default.
• W4311349503 hasRelatedWork W2905624307 @default.
• W4311349503 hasRelatedWork W2910499475 @default.
• W4311349503 hasRelatedWork W4353020407 @default.
• W4311349503 hasVolume "2" @default.
• W4311349503 isParatext "false" @default.
• W4311349503 isRetracted "false" @default.
• W4311349503 workType "article" @default.